Search Images Maps Play YouTube News Gmail Drive More »
Sign in
Screen reader users: click this link for accessible mode. Accessible mode has the same essential features but works better with your reader.


  1. Advanced Patent Search
Publication numberUS3894530 A
Publication typeGrant
Publication dateJul 15, 1975
Filing dateJul 6, 1973
Priority dateJul 6, 1973
Publication numberUS 3894530 A, US 3894530A, US-A-3894530, US3894530 A, US3894530A
InventorsHerbert Dardik, Irving I Dardik
Original AssigneeHerbert Dardik, Irving I Dardik
Export CitationBiBTeX, EndNote, RefMan
External Links: USPTO, USPTO Assignment, Espacenet
Method for repairing, augmenting, or replacing a body conduit or organ
US 3894530 A
The umbilical cord is used for grafts in the vascular system or other body conduits, such as the ureter.
Previous page
Next page
Claims  available in
Description  (OCR text may contain errors)

United States Patent [1 1 Dardik et al.

[451 July 15,1975

Dardik, 806 Washburn St., Teaneck, NJ. 07666 [22] Filed: July 6, 1973 [21] Appl. No.: 376,948

[52] U.S. Cl 128/1 R; 3/1; 3/l.4; 128/334 R [51] Int. Cl. A61B 19/00; A6lF l/24 [58] Field of Search 3/l, DIG.1, 1.4; 128/334 R, 334 C, 335.5, 335, l R

[56] References Cited UNITED STATES PATENTS 3,408,659 ll/l968 Thiele et al 3/l 3,562,820 2/l97l Braun 3/DIG. 1

OTHER PUBLICATIONS The Use of Umbilical Cord for Reconstruction of Abdominal Wall Defects by Frederick C. Heaton et al., Surgical Forum, Vol. 21, 1970, pp. 56-57.

Preparation and Use of Freeze-Dried Arterial Homografts by O. Creech et al., Annals of Surgery, Vol. 140, No. 1, July, 1954, pp. 35-43.

Primary ExaminerRonald L. Frinks Attorney, Agent, or Firm-Blum Moscovitz Friedman & Kaplan ABSTRACT The umbilical cord is used for grafts in the vascular system or other body conduits, such as the ureter.

5 Claims, No Drawings 1 METHOD FOR REPAIRING, AUGMENTING, OR REPLACING A BODY CONDUIT OR ORGAN A major problem in vascular reconstructive surgery is how effectively blood to organs and tissues whose blood vessels are inadequate either through congenital defects or acquired disorders such as trauma, arteriosclerosis and other diseases. Various techniques and materials have been devised to excise and replace blood vessels, to bypass blood vessels, and to patch, i.e., widen the channel of vessels. Initially arterial homografts (human arteries) were used to restore continuity but limited supply, inadequate sizes, development of aneurysms and atherosclerosis necessitated the search for a better substitute. A great advance was the development of the partially porous and pliable plastic cloth graft.

The following is a list of the various problems which one runs into with artificially made grafts:

1. Infection in a foreign body graft is catastrophic,

often leading to hemorrhage, sepsis and death.

2. The inner lining is thrombogenic, predisposed to clotting of the graft and distal embolism of the clot.

3. The rigidity of cloth grafts may result in twisting and kinking, especially in areas of crossing a joint.

4. Because of clotting difficulties, smaller caliber artificial grafts are frequently unsuccessful.

The many problems posed by artificially manufactured prostheses have led investigators again to seek newer and better methods. These include new techniques of cleaning out an artery such as carbodissection, widening arteries by dilatation, development of bovine heterografts, creating collagen tubes within the recipient patient for later use as a graft (Silicone Mandrel).

Saphenous veins, both autografts (patient is donor) and allografts or homografts (from another human), are now being used to advantage. However, there are problems of unavailability, small size, non uniform caliber, time required for harvesting, intraluminal valves and easy twisting leading to occlusion. The number of new methods being continually devised attests to the need for a better material.

According to the present invention, the structures of the human umbilical cord are used for grafts in the vascular system or other body conduits such as the ureter, in mammals, particularly primates, including man. At birth, after division from the baby, the cord itself is traditionally discarded. The umbilical cord is composed of a vein and two arteries surrounded by a substance called Whartons jelly. It varies in length from inches to almost 2 feet. It is highly flexible and strong. Both arteries and the vein are suitable for use in surgery. Composite grafts and patches can be made in various sizes and shapes. A list of uses follows, either as a conduit or as a patch of any kind in the body:

1. Arterial substitute 2. Vein substitute 3. Ureter substitute 4. Common bile duct substitute 5. As an arteriovenous fistula for hemodialysis 6. As a patch to close any visceral or vascular defect, or to wrap around and protect a suture line of any kind.

The umbilical cord may be used fresh or as a stored homograft (frozen or in a preservative). It may require treatment with antibiotics or other chemicals or drugs and x-ray treatment for sterilization. It may be antigenic and require treatment, for example with enzymes, to remove any antigenic substances. The cord may be freeze dried or stored in a cold environment or preserved in other known ways as to be used as an autograft if necessary for the baby whenever needed at a future date. The cord may be somewhat coiled and may require mechanical or chemical techniques to straighten it out if necessary. Cords from premature babies or from early pregnancy can be used (i.e., in

smaller vessels).

The advantages of using umbilical vessels as a conduit or a patch are as follows:

1. easy availability 2. marked flexibility 3. marked strength 4. highly smooth, natural inner lining may inhibit clotting 5. less likely to become infected 6. relative lack of antigenicity 7. uniform diameter 8. variable size available for both large and small vessels 9. good length 10. contains 3 vessels each of which can be used EXAMPLE The following example illustrates the technique of vascular surgical interposition of the umbilical cord vessel derived from the human, into the abdominal aorta of an animal, for example a dog and a baboon.

The animal, in this case a baboon, was prepared under general anesthesia and sterile conditions for making an abdominal incision. The baboon was prepared and shaved and a longitudinal incision was made in the midline of the abdomen. The incision extended from the xythoid to the pubic area and was carried down through the midline and into the peritoneal cavity. Bleeding vessels were clamped and ligated with 3-0 plyglycollic acid sutures. The peritoneal cavity was entered and the viscera and bowel were explored for any other diseases. The animal was found to be normal. The bowel and viscera were walled off with cloth pads and retractors. The peritoneum overlying the aorta was incised and the aorta immobilized by sharp and blunt dissection. Lumbar arteries were individually clamped and ligated with 3-0 silk suture so that the segment of abdominal aorta extending from the infra-renal arteries to the bifurcation of the aorta was immobilized. The entire segment of abdominal aorta was thus made available for transplant of the umbilical cord. During preparation of the abdominal aorta of the baboon, another investigator had taken the umbilical cord of an infant (human) that had been born two hours prior to the surgical intervention of the baboon. The cord had been delivered and taken in its entirety and transported in sterile saline solution, packed in ice. The purpose of freezing the umbilical cord in ice was to prevent any further decomposition of the cord structure. The cord, prior to insertion, was washed and irrigated numerous times with sterile Collins solution with antibiotics, in this particular instance, 1 percent cephalosporin solution and 25,000 units of bacitracin per liter of solution. The blood was thoroughly washed out from within the vessels of the cord and the cord was also irrigated with a 1 percent heparin anticoagulant solution. Following this thorough cleansing of the cord, one end of the umbilical vein within the cord which was to be used as the transplant was clamped with a clamp and through the other end a red rubber catheter, No. 14 French, was introduced and the vein was distended. At this point a suitable segment of umbilical graft, approximately 5 centimeters in length, was selected for excision. This segment of cord was then sterilely handled and placed into the operating field. At this point the animal was heparinized with 2,500 units of aqueous heparin given intravenously. The abdominal aorta was then clamped proximally and distally to the segment to be resected. A segment of approximately 3 centimeters in length was resected from the abdominal aorta and an end-toend anastomosis was performed between host aorta and donor umbilical vein, first using continuous 6-0 prolene suture which is a nylon monofilament suture. The distal anastomosis was then performed following flushing of the aorta to rid it of any clot material and debris. Following completion of anastomosis the distal and then the proximal clamps were removed. It was noted that there was no bleeding between the interstices of the sutures, which is unusual, and is felt to be due to the strength and self-sealing gelatinous qualities of the cord structure. Excellent pulses were noted to be present in the graft as well as the distal iliac vessels. The area was lavaged with with saline and suctioned. The retroperitoneum was closed with interrupted 3-0 polyglycollic acid sutures and the viscera was replaced. The animal, throughout the procedure thus far, was stable; the respiration and vital signs were normal. The abdominal wall was then closed in layers using continuous 0 silk for the posterior fascia and peritoneum and interrupted 2-0 silk sutures for the anterior fascia. The skin was approximated with continuous 3-0 nylon suture. The anesthesia used in this procedure was nembutal. The blood loss estimated during the procedure was approximately 50 to cc. The animal tolerated the procedure well and awoke within 30 minutes. Postoperatively on the following day the animal was sitting and walking in its cage, and on the third postoperative day was eating its regular diet and was allowed out of its cage to roam around and climb up and down the walls, and appearedto be in excellent health. The legs were warm and pulses were intact in the extremities.

A number of procedures will become apparent to those skilled in the art. If desired or necessary, the vein or artery of the umbilical cord may be split longitudinally and formed into composites of larger diameter. The umbilical cord or a portion thereof may be used to reinforce, support or seal a weakened area or defect of any body structure, such as the heart, the heart valves or urinary bladder. Such procedures are included within the scope of the claims.

I claim:

1. A method for repairing, augmenting or replacing a vein or artery of the body of a primate which comprises suturing or otherwise securing a portion of a vein or artery of an umbilical cord of a primate into or onto the wall of such body vein or artery.

2. A method as described in claim 1 wherein the umbilical cord is from a human infant.

3. A method as described in claim 1 wherein an artery of the body is repaired, augmented or replaced.

4. A method as described in claim 1 wherein the cord is from a human and said body is that of a primate other than the donor.

5. A method as described in claim 1 wherein a vein of the body is repaired, augmented or replaced.

Patent Citations
Cited PatentFiling datePublication dateApplicantTitle
US3408659 *Jul 21, 1965Nov 5, 1968Thiele HeinrichArtificial blood vessels and process of making same
US3562820 *Aug 21, 1967Feb 16, 1971Bernhard BraunTubular sheet and strip form prostheses on a basis of biological tissue
Referenced by
Citing PatentFiling datePublication dateApplicantTitle
US3974526 *Jan 23, 1975Aug 17, 1976Dardik Irving IVascular prostheses and process for producing the same
US4400833 *Jun 10, 1981Aug 30, 1983Kurland Kenneth ZMeans and method of implanting bioprosthetics
US4466139 *Oct 29, 1980Aug 21, 1984Vettivetpillai KetharanathanVascular prostheses
US4487567 *Mar 24, 1983Dec 11, 1984Possis Medical, Inc.Apparatus for making a vascular graft
US4546499 *Dec 13, 1982Oct 15, 1985Possis Medical, Inc.Method of supplying blood to blood receiving vessels
US4562597 *Apr 29, 1983Jan 7, 1986Possis Medical, Inc.Method of supplying blood to blood receiving vessels
US4601718 *Jul 13, 1984Jul 22, 1986Possis Medical, Inc.Vascular graft and blood supply method
US4915893 *Jul 15, 1983Apr 10, 1990Medtronic, Inc.Method of preparing polyester filament material
US4990131 *Nov 9, 1989Feb 5, 1991Herbert DardikTubular prostheses for vascular reconstructive surgery and process for preparing same
US5110852 *Oct 27, 1988May 5, 1992Rijksuniversiteit Te GroningenFilament material polylactide mixtures
US5114672 *Aug 27, 1990May 19, 1992Cryo-Cell International, Inc.Method for preserving blood fluid
US5713948 *Jul 19, 1995Feb 3, 1998Uflacker; RenanAdjustable and retrievable graft and graft delivery system for stent-graft system
US5776186 *Sep 25, 1997Jul 7, 1998Endotex Interventional Systems, Inc.Adjustable and retrievable graft and graft delivery system for stent-graft system and methods of implantation
US5865723 *Dec 29, 1995Feb 2, 1999Ramus Medical TechnologiesMethod and apparatus for forming vascular prostheses
US6077217 *Jun 25, 1997Jun 20, 2000Ramus Medical Technologies, Inc.System and method for assembling graft structures
US6494904Dec 27, 1996Dec 17, 2002Ramus Medical TechnologiesMethod and apparatus for forming vascular prostheses
US6630000 *Nov 19, 1999Oct 7, 2003Bonutti 2003 Trust-AMethod of using body tissue
US6905517Oct 24, 2002Jun 14, 2005Bonutti Ip, LlpTissue grafting material
US6989029Feb 21, 2003Jan 24, 2006Bonutti Ip, LlcTissue cage
US6990982Mar 12, 2003Jan 31, 2006Bonutti Ip, LlcMethod for harvesting and processing cells from tissue fragments
US7070557Mar 4, 2004Jul 4, 2006Marctec, LlcTissue graft material and method of making
US7134437Mar 22, 2002Nov 14, 2006Bonutti Ip, LlcMethod for utilizing human tissue
US7294144 *May 10, 1999Nov 13, 2007Schneider James RPreserved implantable vessel derived from a human umbilical cord or placenta
US7462200Nov 23, 2005Dec 9, 2008Marctec, LlcMethod for tissue grafting
US7727283Mar 4, 2004Jun 1, 2010P Tech, Llc.Tissue stabilizing implant method
US7896880Nov 15, 2001Mar 1, 2011P Tech, LlcApparatus and method for tissue removal
US8747439Jul 10, 2006Jun 10, 2014P Tech, LlcMethod of using ultrasonic vibration to secure body tissue with fastening element
US8808329Apr 3, 2012Aug 19, 2014Bonutti Skeletal Innovations LlcApparatus and method for securing a portion of a body
US8814902Jul 31, 2006Aug 26, 2014Bonutti Skeletal Innovations LlcMethod of securing body tissue
US8845687Sep 17, 2013Sep 30, 2014Bonutti Skeletal Innovations LlcAnchor for securing a suture
US8845699Mar 6, 2012Sep 30, 2014Bonutti Skeletal Innovations LlcMethod of securing tissue
US9770238Feb 23, 2004Sep 26, 2017P Tech, LlcMagnetic positioning apparatus
US9814563 *Apr 25, 2015Nov 14, 2017David M. HogansonHemodynamically optimized shunt
US20020040246 *Nov 21, 2001Apr 4, 2002Bonutti Peter M.Tissue press and system
US20020055755 *Nov 15, 2001May 9, 2002Bonutti Peter M.Apparatus and method for tissue removal
US20020099401 *Mar 22, 2002Jul 25, 2002Bonutti Petel M.Apparatus and method for tissue removal
US20030050708 *Oct 24, 2002Mar 13, 2003Bonutti Peter M.Tissue grafting material
US20030130744 *Feb 21, 2003Jul 10, 2003Bonutti Peter M.Tissue cage
US20040126404 *Jul 29, 2003Jul 1, 2004University Of Queensland Of St. LuciaImplant material
US20040172140 *Mar 4, 2004Sep 2, 2004Bonutti Peter M.Tissue stabilizing implant
US20080268017 *May 15, 2008Oct 30, 2008The University Of Queensland Of St. LuciaMethod of producing tissue by placing a molding support within a body cavity
DE3390385C2 *Dec 8, 1983Jul 7, 1994Possis Medical IncGefäßimplantate
EP0070328A1 *Jul 21, 1981Jan 26, 1983Theurer, Karl Eugen, of egg membranes and umbilical cord in unmodified or modified form
WO1982000091A1 *Oct 29, 1980Jan 21, 1982V KetharanathanVascular prostheses
WO1982004390A1 *Jun 8, 1982Dec 23, 1982Kenneth Z KurlandMeans and method of implanting bioprosthetics
WO1997003624A1 *Jul 17, 1996Feb 6, 1997Renan UflackerAdjustable and retrievable graft and graft delivery system for stent-graft system and methods of implantation
WO1998025543A1Dec 10, 1997Jun 18, 1998Purdue Research FoundationTubular submucosal graft constructs
WO1998025546A1Dec 10, 1997Jun 18, 1998Cook Biotech, Inc.Tubular grafts from purified submucosa
WO2008042441A1 *Oct 3, 2007Apr 10, 2008Anthrogenesis CorporationUse of umbilical cord biomaterial for ocular surgery
U.S. Classification600/36, 623/1.41
International ClassificationB29C65/62, A61L27/36
Cooperative ClassificationA61L27/3625, A61L27/3641, A61L27/507, B29C65/62, B29C66/5221, B29C66/1142
European ClassificationB29C65/62, B29C66/5221, B29C66/1142, A61L27/50E, A61L27/36B10, A61L27/36F
Legal Events
Apr 22, 1991ASAssignment
Effective date: 19841224
Apr 22, 1991AS99Other assignments
Jun 19, 1984PSPatent suit(s) filed